← Back to Search

Implantable Cardioverter Defibrillator

Arm 2 (shock only) for Sudden Cardiac Death (APPRAISE ATP Trial)

N/A
Waitlist Available
Led By Claudio Schuger, M.D.
Research Sponsored by Boston Scientific Corporation
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up from 60 days post implant up to five years
Awards & highlights

APPRAISE ATP Trial Summary

This trial will test if a common ICD setting is just as effective as a setting that includes a feature designed to prevent unnecessary shocks.

Eligible Conditions
  • Sudden Cardiac Death

APPRAISE ATP Trial Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~from 60 days post implant up to five years
This trial's timeline: 3 weeks for screening, Varies for treatment, and from 60 days post implant up to five years for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Time-to-First All-Cause Shock
Secondary outcome measures
Time to first appropriate shock
Time to first inappropriate shock
• All-cause mortality

APPRAISE ATP Trial Design

2Treatment groups
Experimental Treatment
Active Control
Group I: Shock onlyExperimental Treatment1 Intervention
Once tachycardia has been detected and duration met, this group would receive shock therapy only.
Group II: ATP and ShockActive Control1 Intervention
Once tachycardia has been detected and duration met, this group would receive antitachycardia pacing prior to shock therapy.
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Arm 2 (shock only)
2016
N/A
~2600

Find a Location

Who is running the clinical trial?

Boston Scientific CorporationLead Sponsor
719 Previous Clinical Trials
930,798 Total Patients Enrolled
Claudio Schuger, M.D.Principal InvestigatorUniversity of Rochester Clincal Cardiovascular Research Center

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

What is the number of health centers that are conducting this clinical investigation in the city?

"Bryn Mawr Medical Specialists in Bryn Mawr, Pennsylvania, Richard A. Henson Research Institute of Peninsula Regional Medical Center in Salisbury, Maryland and Mount Carmel Columbus Cardiology Consultants in Westerville Ohio are a few of the 100 sites that patients can attend for this study."

Answered by AI

Is recruitment for this clinical investigation ongoing?

"Per information posted on ClinicalTrials.gov, this medical trial is not presently recruiting patients. It was initially launched on September 30th 2016 and last updated December 1st 2022. Despite its inactive status, there are 93 other clinical trials actively registering participants at the moment."

Answered by AI

Who else is applying?

What state do they live in?
Florida
Virginia
How old are they?
18 - 65
What site did they apply to?
: Cardiovascular Consultants Medical Group
Brevard Cardiovascular Research Associates, Inc
What portion of applicants met pre-screening criteria?
Met criteria
Did not meet criteria
Recent research and studies
clinicaltrials.govStudy
Assessment of Primary Prevention Patients Receiving An ICD - Systematic Evaluation of ATP
2016. "Assessment of Primary Prevention Patients Receiving An ICD - Systematic Evaluation of ATP". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT02923726.
~306 spots leftby Apr 2025
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top